News (healthcare)

 

Schreiner MediPharm and SCHOTT Pharma present new RFID solution

Pharma label expert Schreiner MediPharm (Oberschleißheim, Germany) and SCHOTT Pharma (Mainz, Germany), the specialist in drug containment and delivery solutions for medications, have been engaged in a partnership for several years. Its objective is to develop new smart concepts that add functional value to prefilled syringes. At the PDA Universe of Pre-Filled Syringes and Injection Devices Conference in California, both companies have now for the first time presented a coordinated, newly developed solution to equip prefilled syringes with RFID. The combination of syringe and smart label opens up diverse opportunities to optimise hospital routines, among other things.

Read more …

 

Health patches – Henkel and Quad Industries take partnership to the next level

Henkel (Düsseldorf, Germany), a global leader in material technologies and Quad Industries (Sint-Niklaas, Belgium), a specialist in printed electronics, have developed a new concept to enable innovations for smart health patches with accelerated speed to market at lower cost. The partners are offering a demo package of twelve electrodes that customers can order online. The demo package is designed to allow engineers to quickly test the functionalities of their concepts, significantly reducing the development time by up to three months and lowering the overall design costs.

Read more …

 

Fraunhofer IZM: Sensor bracelet measures a range of environmental forces to improve the treatment of lung diseases

Tiny particulates or noxious gases: From the day they are born, all people are exposed to a range of environmental forces. These forces constitute the exposome and affect the health and wellbeing of people around the world. A European research project has been set up to explore how the exposome affects the course of lung diseases. The microelectronics specialists at Fraunhofer IZM are on board and have developed a unique sensor bracelet that can pick up even tiniest concentrations of more than 40 individual harmful substances. The collected clinical data will show how these affect the lives of patients and may feed into more targeted and customised treatments.

Read more …

Event diary

Currently there are no events.